VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
19237
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1924
Interactions with Platform & by Email
PARTICIPANTS
383
Unique # Participated
VALIDATIONS
172
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEPTEMBER 2020
TABLES
126
PAGES
202
EDITION
8
PRICE
USD $4950
Easy Growth Opportunities Often Go Unnoticed. Find Your "Low Hanging Fruit".
Top Markets for Drug Device Combination Products.
Amid the COVID-19 crisis, the global market for Drug Device Combination Products estimated at US$90.3 Billion in the year 2020, is projected to reach a revised size of US$133.3 Billion by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Drug Eluting Stents, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$14 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Infusion Pumps segment is readjusted to a revised 5.6% CAGR for the next 7-year period.
The Drug Device Combination Products market in the U.S. is estimated at US$24.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$28.1 Billion by the year 2027 trailing a CAGR of 8.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
In the global Photodynamic Therapy segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2 Billion in the year 2020 will reach a projected size of US$2.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$17.9 Billion by the year 2027, while Latin America will expand at a 6.1% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 202-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Laboratories; Alcon, a Novartis Company; Allergan PLC; Arrow International, Inc.; Bausch & Lomb, Inc.; Boston Scientific Corporation; C.R. Bard, Inc.; CareFusion Corporation; Ethicon US LLC; Medline Industries, Inc.; Medtronic PLC; Mylan NV; Stryker Corporation; Terumo Corporation; W. L. Gore & Associates, Inc.
» Segment (Drug Eluting Stents, Infusion Pumps, Photodynamic Therapy, Prefilled Syringes, Antimicrobial Wound Dressings, Inhalers, Transdermal Patches, Other Drug Device Combination Products)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Drug Device Combination Products Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Drug Device Combination Products Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Drug Device Combination Products Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Drug Device Combination Products Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Drug Eluting Stents (Segment) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Drug Eluting Stents (Segment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Drug Eluting Stents (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Infusion Pumps (Segment) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Infusion Pumps (Segment) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Infusion Pumps (Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Photodynamic Therapy (Segment) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Photodynamic Therapy (Segment) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Photodynamic Therapy (Segment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Prefilled Syringes (Segment) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 |
| Prefilled Syringes (Segment) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Prefilled Syringes (Segment) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Antimicrobial Wound Dressings (Segment) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Antimicrobial Wound Dressings (Segment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Antimicrobial Wound Dressings (Segment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Inhalers (Segment) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 |
| Inhalers (Segment) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Inhalers (Segment) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 |
| Transdermal Patches (Segment) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025 |
| Transdermal Patches (Segment) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017 |
| Transdermal Patches (Segment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Other Drug Device Combination Products (Segment) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Other Drug Device Combination Products (Segment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Other Drug Device Combination Products (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Drug Device Combination Products Market Share (in %) by Company: 2019 & 2025 |
| United States Drug Device Combination Products Market Estimates and Projections in US$ Million by Segment: 2018 to 2025 |
| Drug Device Combination Products Market in the United States by Segment: A Historic Review in US$ Million for 2009-2017 |
| United States Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025 |
| Canadian Drug Device Combination Products Historic Market Review by Segment in US$ Million: 2009-2017 |
| Drug Device Combination Products Market in Canada: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025 |
| JAPAN |
| Japanese Market for Drug Device Combination Products: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025 |
| Drug Device Combination Products Market in Japan: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017 |
| Japanese Drug Device Combination Products Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Drug Device Combination Products Market Growth Prospects in US$ Million by Segment for the Period 2018-2025 |
| Drug Device Combination Products Historic Market Analysis in China in US$ Million by Segment: 2009-2017 |
| Chinese Drug Device Combination Products Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| EUROPE |
| Market Facts & Figures |
| European Drug Device Combination Products Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Drug Device Combination Products Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Drug Device Combination Products Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Drug Device Combination Products Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2018-2025 |
| Drug Device Combination Products Market in Europe in US$ Million by Segment: A Historic Review for the Period 2009-2017 |
| European Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| FRANCE |
| Drug Device Combination Products Market in France by Segment: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Drug Device Combination Products Historic Market Scenario in US$ Million by Segment: 2009-2017 |
| French Drug Device Combination Products Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| GERMANY |
| Drug Device Combination Products Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025 |
| German Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2009-2017 |
| German Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Drug Device Combination Products Market Growth Prospects in US$ Million by Segment for the Period 2018-2025 |
| Drug Device Combination Products Historic Market Analysis in Italy in US$ Million by Segment: 2009-2017 |
| Italian Drug Device Combination Products Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| UNITED KINGDOM |
| United Kingdom Market for Drug Device Combination Products: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025 |
| Drug Device Combination Products Market in the United Kingdom: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017 |
| United Kingdom Drug Device Combination Products Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| SPAIN |
| Spanish Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025 |
| Spanish Drug Device Combination Products Historic Market Review by Segment in US$ Million: 2009-2017 |
| Drug Device Combination Products Market in Spain: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025 |
| RUSSIA |
| Russian Drug Device Combination Products Market Estimates and Projections in US$ Million by Segment: 2018 to 2025 |
| Drug Device Combination Products Market in Russia by Segment: A Historic Review in US$ Million for 2009-2017 |
| Russian Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2018-2025 |
| Drug Device Combination Products Market in Rest of Europe in US$ Million by Segment: A Historic Review for the Period 2009-2017 |
| Rest of Europe Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Asia-Pacific Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Drug Device Combination Products Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 |
| Asia-Pacific Drug Device Combination Products Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
| Drug Device Combination Products Market in Asia-Pacific by Segment: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Drug Device Combination Products Historic Market Scenario in US$ Million by Segment: 2009-2017 |
| Asia-Pacific Drug Device Combination Products Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| AUSTRALIA |
| Drug Device Combination Products Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025 |
| Australian Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2009-2017 |
| Australian Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| INDIA |
| Indian Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025 |
| Indian Drug Device Combination Products Historic Market Review by Segment in US$ Million: 2009-2017 |
| Drug Device Combination Products Market in India: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025 |
| SOUTH KOREA |
| Drug Device Combination Products Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025 |
| South Korean Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2009-2017 |
| Drug Device Combination Products Market Share Distribution in South Korea by Segment: 2009 VS 2019 VS 2025 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Market for Drug Device Combination Products: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025 |
| Drug Device Combination Products Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017 |
| Rest of Asia-Pacific Drug Device Combination Products Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| LATIN AMERICA |
| Latin American Drug Device Combination Products Market Trends by Region/Country in US$ Million: 2018-2025 |
| Drug Device Combination Products Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 |
| Latin American Drug Device Combination Products Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
| Latin American Drug Device Combination Products Market Growth Prospects in US$ Million by Segment for the Period 2018-2025 |
| Drug Device Combination Products Historic Market Analysis in Latin America in US$ Million by Segment: 2009-2017 |
| Latin American Drug Device Combination Products Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| ARGENTINA |
| Argentinean Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2018-2025 |
| Drug Device Combination Products Market in Argentina in US$ Million by Segment: A Historic Review for the Period 2009-2017 |
| Argentinean Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| BRAZIL |
| Drug Device Combination Products Market in Brazil by Segment: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Brazilian Drug Device Combination Products Historic Market Scenario in US$ Million by Segment: 2009-2017 |
| Brazilian Drug Device Combination Products Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| MEXICO |
| Drug Device Combination Products Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025 |
| Mexican Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2009-2017 |
| Mexican Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| REST OF LATIN AMERICA |
| Rest of Latin America Drug Device Combination Products Market Estimates and Projections in US$ Million by Segment: 2018 to 2025 |
| Drug Device Combination Products Market in Rest of Latin America by Segment: A Historic Review in US$ Million for 2009-2017 |
| Rest of Latin America Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| MIDDLE EAST |
| The Middle East Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Drug Device Combination Products Market in the Middle East by Region/Country in US$ Million: 2009-2017 |
| The Middle East Drug Device Combination Products Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
| The Middle East Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025 |
| The Middle East Drug Device Combination Products Historic Market by Segment in US$ Million: 2009-2017 |
| Drug Device Combination Products Market in the Middle East: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025 |
| IRAN |
| Iranian Market for Drug Device Combination Products: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025 |
| Drug Device Combination Products Market in Iran: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017 |
| Iranian Drug Device Combination Products Market Share Analysis by Segment: 2009 VS 2019 VS 2025 |
| ISRAEL |
| Israeli Drug Device Combination Products Market Estimates and Forecasts in US$ Million by Segment: 2018-2025 |
| Drug Device Combination Products Market in Israel in US$ Million by Segment: A Historic Review for the Period 2009-2017 |
| Israeli Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| SAUDI ARABIA |
| Saudi Arabian Drug Device Combination Products Market Growth Prospects in US$ Million by Segment for the Period 2018-2025 |
| Drug Device Combination Products Historic Market Analysis in Saudi Arabia in US$ Million by Segment: 2009-2017 |
| Saudi Arabian Drug Device Combination Products Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| UNITED ARAB EMIRATES |
| Drug Device Combination Products Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025 |
| United Arab Emirates Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2009-2017 |
| Drug Device Combination Products Market Share Distribution in United Arab Emirates by Segment: 2009 VS 2019 VS 2025 |
| REST OF MIDDLE EAST |
| Drug Device Combination Products Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025 |
| Rest of Middle East Drug Device Combination Products Historic Market Analysis in US$ Million by Segment: 2009-2017 |
| Rest of Middle East Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| AFRICA |
| African Drug Device Combination Products Market Estimates and Projections in US$ Million by Segment: 2018 to 2025 |
| Drug Device Combination Products Market in Africa by Segment: A Historic Review in US$ Million for 2009-2017 |
| African Drug Device Combination Products Market Share Breakdown by Segment: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 8 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com